Anemia Treatment Injection Franchise in Ahmedabad

Darbepoetin Alfa Injection Supplier in Mumbai

CKD Anemia Injection Distributor in Delhi

Renal Care Injection Manufacturer in Bangalore

Hematology Injection Stockist in Hyderabad
Darbepoetin Injection Exporter in Chandigarh

Home/Products /darbepoetin-alfa-60mcg-injection

Darbot 60 injection

Composition : Darbepoetin alfa (60mcg) Injection

Dosage Form : Injection

Packaging Type : Pre-Filled Syringe

Packaging : 60mcg

Price : ₹1/-

Darbepoetin Alfa 60mcg injection is an erythropoiesis-stimulating agent (ESA) used for managing anemia associated with chronic kidney disease and chemotherapy-induced anemia.

It works by stimulating the bone marrow to produce red blood cells, helping improve hemoglobin levels and enhance oxygen-carrying capacity in patients suffering from anemia.

This injection is widely prescribed in chronic kidney disease management, dialysis patient care, and oncology-related anemia therapy, helping reduce fatigue and improve patient energy levels and overall well-being.

With strong clinical significance in nephrology and oncology treatment protocols, consistent hospital demand, and broad acceptance among healthcare professionals, this formulation strengthens institutional therapy portfolios and supports sustained therapeutic utilization.

Read More

About the Product

Darbepoetin Alfa 60mcg injection is an erythropoiesis-stimulating agent (ESA) used for managing anemia associated with chronic kidney disease and chemotherapy-induced anemia.

It works by stimulating the bone marrow to produce red blood cells, helping improve hemoglobin levels and enhance oxygen-carrying capacity in patients suffering from anemia.

This injection is widely prescribed in chronic kidney disease management, dialysis patient care, and oncology-related anemia therapy, helping reduce fatigue and improve patient energy levels and overall well-being.

With strong clinical significance in nephrology and oncology treatment protocols, consistent hospital demand, and broad acceptance among healthcare professionals, this formulation strengthens institutional therapy portfolios and supports sustained therapeutic utilization.

Some patients may experience increased blood pressure, headache, nausea, fatigue, or pain at the injection site. These side effects are generally mild and temporary. Rare but serious reactions such as blood clots or allergic reactions may occur and should be reported immediately to a healthcare professional.

Darbot 60 Injection is indicated for the treatment of anemia in patients with chronic kidney disease, including those undergoing dialysis and those not on dialysis. It is also used to manage anemia in patients receiving chemotherapy for certain cancers, helping improve red blood cell levels and reduce symptoms such as fatigue and weakness.

This injection should be administered under the supervision of a qualified healthcare professional. Regular monitoring of hemoglobin levels and blood pressure is necessary during treatment to ensure safe and effective therapy. The dosage should be adjusted according to the patient’s medical condition and response.

Store in a refrigerator at 2°C–8°C. Do not freeze. Protect from direct light and keep the injection in its original packaging. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation